Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study.
Mahmoud D, Yassa M, Alvarado L, Lambert C, Meterissian S, Anderson D, Tremblay F, Otaky N, Keyserlingk J, Panet-Raymond V, Kopek N, David M, Duclos M, Pembroke C, Fleiszer D, Meguerditchian AN, Loutfi A, Lavigne D, Hijal T. Mahmoud D, et al. Among authors: david m. Radiother Oncol. 2024 Nov;200:110510. doi: 10.1016/j.radonc.2024.110510. Epub 2024 Aug 30. Radiother Oncol. 2024. PMID: 39218040 Free article. Clinical Trial.
Targeted Intraoperative Radiation Therapy during Breast-Conserving Surgery for Patients with Early Stage Breast Cancer: A Phase II Single Center Prospective Trial.
Martinez C, Meterissian S, Saidi A, Tremblay F, Meguerditchian AN, Fleiszer D, Lambert C, David M, Panet-Raymond V, Abdulkarim B, Hijal T. Martinez C, et al. Among authors: david m. Adv Radiat Oncol. 2023 Apr 8;8(5):101236. doi: 10.1016/j.adro.2023.101236. eCollection 2023 Sep-Oct. Adv Radiat Oncol. 2023. PMID: 37408681 Free PMC article.
Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study.
Niazi TM, Vuong T, Azoulay L, Marijnen C, Bujko K, Nasr E, Lambert C, Duclos M, Faria S, David M, Cummings B. Niazi TM, et al. Among authors: david m. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e305-10. doi: 10.1016/j.ijrobp.2012.03.062. Epub 2012 May 30. Int J Radiat Oncol Biol Phys. 2012. PMID: 22652101 Clinical Trial.
Hypofractionated radiotherapy for favorable risk prostate cancer.
Rene N, Faria S, Cury F, David M, Duclos M, Shenouda G, Souhami L. Rene N, et al. Among authors: david m. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):805-10. doi: 10.1016/j.ijrobp.2009.05.047. Int J Radiat Oncol Biol Phys. 2010. PMID: 20510194
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results.
Cury FL, Duclos M, Aprikian A, Patrocinio H, Kassouf W, Shenouda G, Faria S, David M, Souhami L. Cury FL, et al. Among authors: david m. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1417-23. doi: 10.1016/j.ijrobp.2011.05.025. Epub 2011 Jul 23. Int J Radiat Oncol Biol Phys. 2012. PMID: 21784585
3,386 results